Danaher Corporation (NYSE:DHR) is reporting second quarter earnings results on Thursday 23rd July 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 1.08 per share.
For the full year, analysts predict revenues of $ 20500.70 million, while looking forward to income of $ 4.98 per share.
The Company Outlook
Full Year 2020 bottomline are predicted in a range of $ 4.80 ~ $ 4.90 per share
Click Here For More Historical Outlooks Of Danaher Corporation
Previous Quarter Performance
Danaher Corporation came out with income for the first quarter of $ 1.05 per share, from the revenue of $ 4,343.00 million. The quarterly earnings improved 36.22 percent while revenues compared with the same quarter last year.
Wall street analysts are predicting, DHR to report 1Q20 income of $ 1.01 per share from revenue of $ 4,290.00 million. The bottom line results beat street analysts by $ 0.04 or 3.96 percent, at the same time, top line results outshined analysts by $ 53.00 million or 1.24 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Danaher Corporation
Stock Performance
According to the previous trading day, closing price of DHR was $ 195.61, representing a 63.55 % increase from the 52 week low of $ 119.60 and a 0.8 % decrease over the 52 week high of $ 197.18.
The company has a market capital of $ 138.30 billion and is part of the Healthcare sector and Diagnostics & Research industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”DHR” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Recent Stock Dividend Announcement
On May 5, 2020, the board of directors authorized quarterly dividend of $ 0.18 per share to holders of record as of the close of business on June 26, 2020, with payment date of July 31, 2020 and ex-dividend date on June 25, 2020.
Conference Call
Danaher Corporation will be hosting a conference call at 8:00 AM eastern time on 23rd July 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.danaher.com
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The companys Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
